文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

硫胺素、抗坏血酸与氢化可的松代谢复苏鸡尾酒治疗脓毒症:随机对照试验的Meta分析及试验序贯分析

Thiamine, Ascorbic Acid, and Hydrocortisone As a Metabolic Resuscitation Cocktail in Sepsis: A Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis.
PubMed 文献 · Crit Care Med · 2021-01-01
一句话结论在ICU脓毒症患者中,硫胺素+抗坏血酸+氢化可的松可小幅改善72小时内SOFA评分变化(WMD -0.82),但对肾衰竭和死亡率的影响仍不明确。

该研究为系统评价与Meta分析,纳入8项随机对照试验共1335例ICU脓毒症或脓毒症休克患者,比较硫胺素、抗坏血酸与氢化可的松联合方案与标准治疗或安慰剂。主要结局72小时内SOFA评分变化:干预组中位均值改善-3.2,对照组-1.8,加权均数差-0.82(95%CI -1.15至-0.48)。血管活性药物使用时间显著缩短,但ICU死亡率与肾脏复合结局(AKI KDIGO 3期或需肾脏替代治疗)无显著差异。作者认为SOFA改善幅度 modest,临床相关性存疑。

要点

  • 在ICU脓毒症或脓毒症休克患者中,硫胺素+抗坏血酸+氢化可的松联合方案使72小时内SOFA评分变化优于对照,WMD -0.82(95%CI -1.15至-0.48),8项RCT、n=1253。
  • 该联合方案显著缩短血管活性药物使用时间(6项RCT),但原文未给出具体效应量。
  • ICU死亡率与肾脏复合结局(AKI KDIGO 3期或需肾脏替代治疗)在干预组与对照组间无显著差异(7项RCT)。
  • 作者结论:SOFA改善幅度 modest,临床相关性存疑;对肾衰竭和死亡率的影响仍不明确。
  • 证据纳入8项RCT共1335例,数据同质、漏斗图未提示发表偏倚,但原文未报告证据等级。

适用人群与场景

  • 纳入:入住ICU的脓毒症或脓毒症休克患者(8项RCT,n=1335)。
  • 排除:原文未提及。
  • 场景:ICU。

诊断标准与关键阈值

  • 脓毒症或脓毒症休克诊断标准原文未具体提及;肾脏复合结局定义为急性肾损伤KDIGO 3期或需肾脏替代治疗。
  • 主要结局为72小时内SOFA评分变化。

处置流程与药物剂量

  • 干预为硫胺素、抗坏血酸与氢化可的松联合方案,对照为标准治疗或安慰剂;原文未提及各药物具体剂量、给药途径、频次或疗程。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:系统评价与Meta分析(8项RCT,n=1335例ICU脓毒症或脓毒症休克患者)。
  • 主要结局:72小时内SOFA评分变化,干预组中位均值改善-3.2 vs 对照组-1.8,WMD -0.82(95%CI -1.15至-0.48),8项RCT、n=1253,数据同质,漏斗图未提示发表偏倚。
  • 次要结局:血管活性药物使用时间在干预组显著缩短(6项RCT,原文未给具体效应量);ICU死亡率与肾脏复合结局(AKI KDIGO 3期或需肾脏替代治疗)无显著差异(7项RCT)。
  • 作者结论:SOFA改善幅度 modest,临床相关性存疑;对肾衰竭和死亡率的影响仍不明确。

证据类型、等级与局限

  • 证据类型:随机对照试验的系统评价与Meta分析。
  • 证据等级或推荐强度:原文未提及。
  • 局限:原文未明确列出;作者指出SOFA改善幅度 modest、临床相关性存疑,对肾衰竭和死亡率影响不明确。

对床旁实践的改变

  • 该Meta分析提示硫胺素+抗坏血酸+氢化可的松联合方案可小幅改善72小时内SOFA评分并缩短血管活性药物使用时间,但未显示ICU死亡率或肾脏复合结局获益,不支持将其作为常规复苏方案常规使用。
  • 适用人群为ICU脓毒症或脓毒症休克患者;原文未提及不适用人群。
  • 常见陷阱:将SOFA小幅改善误判为临床硬终点获益;原文未提供药物剂量,不应将研究方案剂量外推为通用推荐。

指南或共识出处

  • 原文未提及具体指南或共识名称;来源期刊为Crit Care Med。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Sepsis is a common condition in the ICU. Despite much research, its prognosis remains poor. In 2017, a retrospective before/after study reported promising results using a combination of thiamine, ascorbic acid, and hydrocortisone called "metabolic resuscitation cocktail" and several randomized controlled trials assessing its effectiveness were performed.

DESIGN: We conducted a systematic review and meta-analysis of randomized controlled trials in septic ICU patients to assess the effects of this combination therapy.

SETTING: PubMed, Embase, and the Cochrane library databases were searched from inception to March of 2021. Data were extracted independently by two authors. The main outcome was the change in Sequential Organ Failure Assessment score within 72 hours. Secondary outcomes included renal composite endpoints (acute kidney injury) Kidney Disease - Improving Global Outcome organization stage 3 or need for renal replacement therapy, vasopressor duration, and 28-day mortality.

SUBJECTS: We included randomized controlled trials with patients admitted to the ICU with sepsis or septic shock.

INTERVENTION: The trials compared a combination of thiamine, ascorbic acid, and hydrocortisone to standard care or placebo in patients admitted to ICU with sepsis or septic shock.

MEASUREMENTS AND MAIN RESULTS: We included eight randomized controlled trials (n = 1,335 patients). Within 72 hours, the median of mean improvement was -1.8 and -3.2 in the control and intervention groups, respectively (eight randomized controlled trials, n = 1,253 patients); weighted mean difference -0.82 (95% CI, -1.15 to -0.48). Data were homogeneous and the funnel plot did not suggest any publication bias. Duration of vasopressor requirement was significantly reduced in the intervention group (six randomized controlled trials). There was no evidence of a difference regarding the ICU mortality and the renal composite outcome (acute kidney injury KDIGO 3 or need for renal replacement therapy, seven randomized controlled trials).

CONCLUSIONS: Metabolic resuscitation cocktail administrated in ICU septic patients improves change in Sequential Organ Failure Assessment score within 72 hours. However, this improvement is modest and its clinical relevance is questionable. The impact on renal failure and mortality remains unclear.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Assouline B, Faivre A, Verissimo T, et al. Thiamine, Ascorbic Acid, and Hydrocortisone As a Metabolic Resuscitation Cocktail in Sepsis: A Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis. Crit Care Med. 2021. PMID: 34582409. doi:10.1097/CCM.0000000000005262

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。